Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 11, 2023
Abstract
Peroxisome
proliferator-activated
receptors
(PPARs)
play
a
crucial
role
in
regulating
carbohydrate
and
lipid
metabolism
are
considered
as
significant
targets
for
treating
metabolic
syndrome
cancers.
There
is
need
to
identify
new
bioactive
ligands
that
can
activate
specific
PPAR
subtypes,
particularly
PPARβ/δ,
which
less
studied
compared
other
isoforms
(α
γ).
Here,
the
ZINC
database
of
clinically
approved
drugs
was
screened
target
PPARβ/δ
receptor,
through
virtual
screening
followed
by
molecular
docking
dynamics
(MD)
simulation.
Among
ligands,
top
five
with
strong
binding
affinity
towards
were
canagliflozin,
empagliflozin,
lumacaftor,
eprosartan,
dapagliflozin.
The
top-scoring
showed
stable
protein-ligand
complexation
(PLC)with
revealed
RMSD
/
RMSF
analysis.
silico
ADMET
prediction
analysis
assessed
pharmacokinetic
profiles
these
wherein
they
favourable
drug-likeness
properties.
These
promising
results
indicate
scope
developing
validating
agonists
disease
models.
Journal of Traditional and Complementary Medicine,
Journal Year:
2023,
Volume and Issue:
14(1), P. 55 - 69
Published: July 13, 2023
Novel
nature
of
the
viral
pathogen
SARS-CoV-2
and
absence
standard
drugs
for
treatment,
have
been
a
major
challenge
to
combat
this
deadly
infection.
Natural
products
offer
safe
effective
remedy,
which
traditional
ethnic
medicine
can
provide
leads.
An
indigenous
poly-herbal
formulation,
Kabasura
Kudineer
from
Siddha
system
was
evaluated
here
using
combination
computational
approaches,
identify
potential
inhibitors
against
two
anti-SARS-CoV-2
targets
-
post-fusion
Spike
protein
(structural
protein)
main
protease
(Mpro,
non-structural
protein).
We
docked
32
phytochemicals
formulation
glycoprotein
Mpro
followed
by
molecular
dynamics
Schrodinger
software.
Drug-likeness
analysis
performed
machine
learning
(ML)
approach
pkCSM.
The
binding
affinity
in
revealed
following
top-five
bioactives:
Quercetin
>
Luteolin
Chrysoeriol
5-Hydroxy-7,8-Dimethoxyflavone
Scutellarein
target,
Gallic
acid
Piperlonguminine
Elemol
Piperine
target.
exhibited
stability
complexation
with
their
respective
viral-targets
favourable
free
energy
change
as
simulations
MM-PBSA
analysis.
In
silico
predicted
pharmacokinetic
profiling
these
ligands
appropriate
drug-likeness
properties.
These
outcomes
provide:
(a)
mechanism
anti-viral
efficacy
targeting
(b)
top
bioactive
lead-molecules
that
may
be
developed
natural
product-based
pharmacotherapy
pleiotropic
protective
effects
leveraged
manage
co-morbidities
associated
COVID-19.
Biology,
Journal Year:
2023,
Volume and Issue:
12(12), P. 1509 - 1509
Published: Dec. 11, 2023
Type
2
diabetes
mellitus
(T2DM)
is
characterized
by
insulin
resistance
and/or
defective
production
in
the
human
body.
Although
antidiabetic
action
of
corn
silk
(CS)
well-established,
understanding
mechanism
(MoA)
behind
this
potential
lacking.
Hence,
study
aimed
to
elucidate
MoA
different
samples
(raw
and
three
extracts:
aqueous,
hydro-ethanolic,
ethanolic)
as
a
therapeutic
agent
for
management
T2DM
using
metabolomic
profiling
computational
techniques.
Ultra-performance
liquid
chromatography-mass
spectrometry
(UP-LCMS),
silico
techniques,
density
functional
theory
were
used
compound
identification
predict
MoA.
A
total
110
out
128
identified
secondary
metabolites
passed
Lipinski’s
rule
five.
The
Kyoto
Encyclopaedia
Genes
Genomes
pathway
enrichment
analysis
revealed
cAMP
hub
signaling
pathway,
which
ADORA1,
HCAR2,
GABBR1
key
target
genes
implicated
pathway.
Since
gallicynoic
acid
(−48.74
kcal/mol),
dodecanedioc
(−34.53
tetradecanedioc
(−36.80
kcal/mol)
interacted
well
with
GABBR1,
respectively,
are
thermodynamically
stable
their
formed
compatible
complexes,
according
post-molecular
dynamics
simulation
results,
they
suggested
drug
candidates
therapy
via
maintenance
normal
glucose
homeostasis
pancreatic
β-cell
function.
Annales d Endocrinologie,
Journal Year:
2024,
Volume and Issue:
85(3), P. 179 - 183
Published: June 1, 2024
During
the
past
years,
several
drugs
have
been
developed
for
treatment
of
obesity.
Some
are
already
used
in
clinical
practice:
orlistat,
GLP-1
receptor
agonists
(RA),
GLP-1/GIP
biagonists
and
melanocortin
4
(MC4R)
agonist,
setmelanotide.
should
be
available
future:
GLP-1/glucagon
biagonists,
GLP-1/GIP/glucagon
triagonists.
These
act
mainly
by
reducing
food
intake
or
fat
absorption.
However,
many
them
show
specific
effects
on
adipose
tissue.
All
these
significant
reduction
mass
and,
more
particularly
visceral
fat.
If
most
drugs,
except
shown
to
increase
energy
expenditure
rodents
with
enhanced
thermogenesis,
this
has
not
yet
clearly
demonstrated
humans.
triagonist
stimulating
glucagon
seem
a
potent
effect
thermogenesis
tissue
thus,
expenditure.
Most
production
adiponectin
reduce
pro-inflammatory
cytokines
GLP-1RAs
size
adipocytes
promote
their
differentiation.
GLP-1RAS
reduce,
tissue,
expression
genes
involved
lipogenesis.
Further
studies
still
needed
clarify
precise
roles,
dedicated
Frontiers in Nutrition,
Journal Year:
2024,
Volume and Issue:
11
Published: Oct. 18, 2024
Obesity,
a
prevalent
global
health
concern,
is
characterized
by
excessive
fat
accumulation,
which
confers
significant
nutritional
and
risks,
including
shortened
lifespan
diminished
wellbeing.
Central
to
the
regulation
of
energy
balance
food
intake
mass
obesity-associated
(FTO)
protein,
modulates
interplay
between
caloric
consumption
expenditure.
Given
its
pivotal
role
in
obesity
regulation,
identification
effective
inhibitors
targeting
FTO
protein
imperative
for
developing
therapeutic
interventions.
Currently
available
anti-obesity
drugs
are
often
plagued
undesirable
side
effects.
In
contrast,
natural
plant-derived
bioactive
compounds
gaining
prominence
pharmaceutical
industry
due
their
efficacy
lower
incidence
adverse
Little
Millet,
traditional
cereal
known
rich
profile
high
satiety
index,
was
investigated
this
study
using
molecular
docking
dynamics
simulation
approach
potential
as
an
agent.
Our
research
demonstrates
that
four
from
Millet
exhibit
superior
binding
energies
ranging
7.22
8.83
kcal/mol,
compared
standard
drug,
orlistat,
has
5.96
kcal/mol.
These
fulfilled
all
drug-like
criteria,
Lipinski,
Ghose,
Veber,
Egan,
Muegge
rules,
exhibited
favorable
profiles
terms
distribution,
metabolism,
prolonged
half-life
without
toxicity.
Conversely,
orlistat
associated
with
hepatotoxicity,
reduced
half-life,
multiple
violations
drug-likeness
parameters,
undermining
efficacy.
Molecular
simulations
Gibbs
free
assessments
revealed
identified
maintain
stable
interactions
key
residues
protein’s
active
site.
We
propose
further
validation
through
extensive
vitro
,
vivo
clinical
studies
ascertain
these
combating
obesity.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(11), P. 1451 - 1451
Published: Oct. 30, 2024
:
Mexican
people
use
Smilax
dominguensis
as
a
traditional
medicine
for
diabetes
control.
Some
reports
have
shown
an
anti-hyperglycemic
effect
in
animal
models.
In
the
current
research,
chemical
bio-guided
fractionation
vitro
and
silico
was
performed
to
identify
compounds
with
hypolipidemic
effects
through
PPARγ/α
dual
agonist
activity
because
they
regulate
genes
involved
energy
storage
burning,
such
GLUT4
FATP.
Plants,
Journal Year:
2022,
Volume and Issue:
11(22), P. 3147 - 3147
Published: Nov. 17, 2022
Inhibition
of
systemic
inflammation
has
been
a
beneficial
strategy
in
treating
several
non-communicable
diseases,
which
represent
one
the
major
causes
mortality
world.
The
Peroxisome
Proliferator-Activated
Receptors
(PPAR)
are
interesting
pharmacological
targets,
since
they
can
act
both
through
metabolic
and
anti-inflammatory
pathways.
Morus
nigra
L.
flavonoids
its
chemical
composition
with
recognized
anti-oxidant
activity
often
associated
activity.
Therefore,
this
study
aimed
to
evaluate
hydroethanolic
extract
M.
leaves’
ability
activate
PPAR
promote
effects
lipopolysaccharide
(LPS)-stimulated
murine
macrophage
cells.
leaf
was
prepared
by
cold
maceration,
profile
obtained
HPLC-DAD.
Activation
α
γ
evaluated
luciferase
reporter
assay.
assessed
measuring
reactive
oxygen
species
(ROS),
nitric
oxide
(NO),
Tumor
Necrosis
Factor-α
(TNF-α)
RAW
264.7
cells
after
stimulation
LPS
from
Escherichia
coli.
HPLC-DAD
analysis
identified
two
compounds:
rutin
isoquercitrin.
showed
agonist
for
types
PPAR,
γ,
although
compounds,
isoquercitrin,
did
not
significantly
receptors.
In
addition,
reduced
production
ROS,
NO,
TNF-α.
Treatment
specific
PPAR-α
antagonist,
GW
6471,
able
partially
block
effect
caused
extract.